© Globe Newswire
26.11.2025
TNG
LISTED
EURONEXT
Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets
News Preview
Strasbourg, France, 27 November 2025, 00:15 a.m. CET – Transgene (Euronext Paris: TNG) had requested the suspension of trading of its shares (ISIN: FR0005175080) on Euronext Paris as from Wednesday, 26 November 2025, before market opening, pending the publication of the results of its capital increase....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
TNG
LISTED
EURONEXT
Transgene Successfully Completes a Fundraising of c. €105 Million
News Preview
This press release may not be distributed directly or indirectly in the United States, Canada, United Kingdom, Australia or Japan....
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
BEAT
LISTED
NASDAQ
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application
News Preview
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced its regulatory strategy following receipt of a Not Substantially Equivalent (NSE) decision on the Company’s 510(k) submission for its 12-lead Electrocardiogram (ECG) Synthesis Software.
Imm...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Newsfile
26.11.2025
HEM
LISTED
TSX
Hemostemix Starts its Roll-up of Cardiology Practices, Acquiring its First Two
News Preview
Calgary, Alberta--(Newsfile Corp. - November 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), is pleased to announce a binding Letter of Intent for the acquisition of the first two cardiology practices under the Company's clinic roll-up and commercialization strategy. The practices of Dr. Roberto Manuel Fernandez-de-Castro and Dr...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
26.11.2025
ZTS
LISTED
NYSE
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
News Preview
Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis (OA) in dogs.
Lenivia is a new antibody therapy that reduces OA pain in dogs for three months with one injection through its novel binding properties to nerve...
Themefolio
Profiler
Peergroup
© Newsfile
26.11.2025
DTR
LISTED
CSE
DiagnosTear Technologies Announces Initiation of a Collaboration with LV Prasad Eye Institute for Advancing the Clinical Validation of TeaRx(TM) Red Eye Diagnostic Test
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) ("DiagnosTear" or the "Company"), a leader in developing cutting-edge point-of-care eye diagnostic solutions, is pleased to announce its scientific collaboration with the renowned LV Prasad Eye Institute (LVPEI) in Hyderabad, India. The part...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
NUTX
LISTED
NASDAQ
NUTEX HEALTH RESPONDS TO SHORT SELLER REPORT
News Preview
HOUSTON, Nov. 26, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), is aware of a short seller report issued on November 25, 2025 by Capybara Research. Based on publicly available information, Capybara Research as an entity seems not to exist. In the past, lawsuits filed against Capybara by other victims of...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
NUVB
LISTED
NYSE
Nuvation Bio to Participate in Upcoming Investor Conferences
News Preview
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, and Philippe Sauvage, Chief Financial Officer of Nuvation Bio, will participate in fireside chats at two upcoming...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
KEQU
LISTED
NASDAQ
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026
News Preview
STATESVILLE, N.C., Nov. 26, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2026 financial results on Wednesday, December 10, 2025 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the re...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
TLRY
LISTED
TSX
Tilray Brands Announces Implementation of Previously Approved 1-for-10 Reverse Stock Split
News Preview
Common Stock Expected to Begin Trading on a Split-Adjusted Basis on December 2, 2025 Common Stock Expected to Begin Trading on a Split-Adjusted Basis on December 2, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
VERA
LISTED
NASDAQ
Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors
News Preview
Vera Therapeutics appoints veteran biotech executive
James R. Meyers to its Board of Directors....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
TPST
LISTED
NASDAQ
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
News Preview
$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full of short-term unregistered warrants $4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full of short-term unregistered warrants...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
26.11.2025
TDOC
LISTED
NYSE
Teladoc Health to Participate in Upcoming Investor Conference
News Preview
NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Chuck Divita, chief executive officer, will participate in the 37th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 2, 2025, at 12:30 p.m. ET. A live audio webcast and replay of the presentat...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
CELC
LISTED
NASDAQ
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
News Preview
MINNEAPOLIS, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that an abstract was accepted for an oral presentation at the 2025 San Antonio Breast Cancer Symposium (SABCS) and is now available on the SABCS website. The 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
MLYS
LISTED
NASDAQ
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
News Preview
RADNOR, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
OBIO
LISTED
NASDAQ
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NEW HOPE, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, reported today that, on November 24, 2025, the Compensatio...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
PCRX
LISTED
NASDAQ
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical
News Preview
-- Lawsuit triggers 30-month stay under the Hatch Waxman Act -- BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it has filed a patent infringement lawsuit in t...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities
News Preview
Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to nitrosamine impurities. Through comprehensive risk assessments, confirmatory testing, and control strategies, the Company is ensuring the safety and compliance of its drug substances and drug products. By investing in site improvemen...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities
News Preview
Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to nitrosamine impurities. Through comprehensive risk assessments, confirmatory testing, and control strategies, the Company is ensuring the safety and compliance of its drug substances and drug products. By investing in site improvemen...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities
News Preview
Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to nitrosamine impurities. Through comprehensive risk assessments, confirmatory testing, and control strategies, the Company is ensuring the safety and compliance of its drug substances and drug products. By investing in site improvemen...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.11.2025
GLG
LISTED
TSX
GLG Life Tech Corporation Reports 2025 Third Quarter Financial Results
News Preview
VANCOUVER, BC / ACCESS Newswire / November 26, 2025 / GLG Life Tech Corporation (NEX:GLG.H) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and nine months ended September 30, 2025. The complete set...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
BAVA
LISTED
CPH
Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen
News Preview
Bavarian Nordic invites shareholders to an information meeting with board and management on Dec 11, 09:00–10:30 CET in Copenhagen. Register by Dec 9....
Themefolio
Profiler
Peergroup
© EQS Newswire
26.11.2025
Q11
LISTED
XETRA
Viromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care
News Preview
AD HOC ANNOUNCEMENTViromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care
Pinneberg, November 26, 2025 – Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), confirms market rumors that the company is in advanced talks with a global MedTech company in the field of wound treatment about signin......
Themefolio
Profiler
Peergroup
© EQS Newswire
26.11.2025
Q11
LISTED
XETRA
Viromed bestätigt Gespräche mit internationalem MedTech-Konzern hinsichtlich Kooperation im Bereich der Wundbehandlung
News Preview
AD-HOC-MITTEILUNG
Viromed bestätigt Gespräche mit internationalem MedTech-Konzern hinsichtlich Kooperation im Bereich der Wundbehandlung
Pinneberg, 26. November 2025 – Die Viromed Medical AG („Viromed“; ISIN: DE000A3MQR65), bestätigt Marktgerüchte, wonach sich die Gesellschaft in fortgeschrittenen Gesprächen mit einem weltweit agierenden MedTech-......
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
CNC
LISTED
NYSE
Recent SNAP Disruptions Highlight Urgent Need for Sustained Action Against Food Insecurity
News Preview
Statewide Effort Aims to Deliver Immediate Relief and Long-Term Solutions for Families in NeedSACRAMENTO, Calif., Nov. 26, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and a company of Centene Corporation (NYSE: CNC), today announced multiple investments in 2025 aimed at tackling rising f...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
PEG
LISTED
CPH
Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority
News Preview
Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
CLBIO
LISTED
STO
Förändringar i ersättningssystemet i USA möjliggör breddning av PFA-marknaden
News Preview
Centers for Medicare & Medicaid Services (CMS) – den myndighet som avgör vilka terapier som är berättigade till ersättning i USA – har gjort en betydande uppdatering av ersättningsmodellen för teknologier inom hjärtablation. I den nyligen publicerade regleringen, som träder i kraft i januari 2026, inkluderas hjärtkateterablation för behandling...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
GLMD
LISTED
NASDAQ
Galmed Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
TEL AVIV, Israel, Nov. 26, 2025 /PRNewswire/ —Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and gastrointestinal oncology indications, reports financial results for the three and nine months ended September 30, 2025 and recent developments.
Fina...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
QNTM
LISTED
NASDAQ
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
News Preview
TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), is pleased to announce that national television network CTV News’ flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company’s allegations of stock market mani...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
VTGN
LISTED
NASDAQ
Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting
News Preview
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, presented exploratory data at The Menopause Society 2025 Annual Meeting in Orlando, Florida. These findings demonstrate PH80’s...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
AHCO
LISTED
NASDAQ
AdaptHealth Corp. to Participate in Upcoming Investor Conference
News Preview
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the BofA Securities Leveraged Finance Conference, being held in Boca Raton, FL, on T...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
RIGL
LISTED
NASDAQ
Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Nov. 26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Piper Sandler 37th Annual Healthcare Conference...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
AADI
LISTED
NASDAQ
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
News Preview
MORRISTOWN, N.J., Nov. 26, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer treatments, today announced that Dave Lennon, PhD, President and CEO, will participate in a fi...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
MURA
LISTED
NASDAQ
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty
News Preview
WALTHAM, Mass. and DUBLIN, Ireland, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA) (“Mural”) announces that, in accordance with the terms of the transaction agreement between XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA Royalty”), XRA 5 Corp. (“Sub”) and Mural announced on August 20, 2025 (the “Transaction Agreement”), the...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
SKYE
LISTED
NASDAQ
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SKYE
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Skye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: SKYE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of SKYE during the c...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
GENI
LISTED
NYSE
CBF to Revolutionize Officiating With Genius Sports’ Semi-Automated Offside Technology in 2026
News Preview
The Confederação Brasileira de Futebol (“CBF”), one of the most prestigious organizations in the world’s game, has selected Genius Sports Limited (“Genius Sports”) (NYSE:GENI) to implement its world-leading semi-automated offside technology (“SAOT”) in 2026.
Genius Sports’ SAOT solution is the leader in world football – used across the Premier Le...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
ENVB
LISTED
NASDAQ
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates
News Preview
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that it has received a Notice of Allowance (NOA) from the United States Patent and Trademark Office (USPTO) for a patent application...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare unveils Pristina Recon DL for mammography – deep learning image reconstruction technology delivering clearer image quality
News Preview
GE HealthCare (Nasdaq: GEHC) announced today that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep learning, Pristina Recon DL sets a new standard in image definition and sharpness.
Breast cancer remains one of the most common cancers among women, with o...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
PRGO
LISTED
NYSE
Perrigo Company plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – PRGO
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Perrigo Company plc (“Perrigo” or “the Company”) (NYSE: PRGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of PRGO during the cl...
Themefolio
Profiler
Peergroup
© Newsfile
26.11.2025
SHRX
LISTED
TSX
Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update
News Preview
Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - November 26, 2025) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company"), announces the release of its condensed interim consolidated financial statements for the three and nine months ended September 30, 2025, and related management discussion and ana...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
DCGO
LISTED
NASDAQ
DocGo Announces Participation at Upcoming December Investor Conferences
News Preview
DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in December:
Noble Capital Markets Emerging Growth Conference (December 3rd)
Lee Bienstock, Chief Executive Officer will partic...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
MBOT
LISTED
NASDAQ
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
News Preview
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
FBLG
LISTED
NASDAQ
FibroBiologics Announces Payoff of Outstanding Debt
News Preview
Repayment of convertible promissory notes strengthens balance sheet and eliminates further dilution from conversions Repayment of convertible promissory notes strengthens balance sheet and eliminates further dilution from conversions...
Themefolio
Profiler
Peergroup
© Newsfile
26.11.2025
HBFG
LISTED
CSE
Happy Belly Food Group Announces 14th Consecutive Record Quarter, and Third Consecutive Quarter of Positive Net Income from Operations
News Preview
Toronto, Ontario--(Newsfile Corp. - November 26, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada is pleased to announce its unaudited financial results and corporate update for the fiscal quarter ended September 30th, 2025."In Q3 20...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
RPRX
LISTED
NASDAQ
Royalty Pharma to Present at Upcoming Investor Conferences
News Preview
NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of December:...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
MRK
LISTED
NYSE
Merck to Participate in the Citi 2025 Global Healthcare Conference
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Chirfi Guindo, chief marketing officer, Human Health, and Dr. Eliav Barr, senior vice president, head of global clinical development and chief medical officer, Merck Research Laboratories, are scheduled to participate in a fireside chat at the Citi 2025 G...
Themefolio
Profiler
Peergroup
© EQS Newswire
26.11.2025
ONCO
LISTED
NEO
Teilnahme an den prestigeträchtigen “Innovation Awards 2025”
News Preview
EQS-Media / 26.11.2025 / 13:05 CET/CEST
Onco-Innovations Ltd. (ISIN: CA68237C1059 / WKN: A3EKSZ), Onco oder das Unternehmen, freut sich bekannt zu geben, dass das Unternehmen zur Teilnahme an den “Innovation Awards 2025” der “University of Alberta” in Edmonton, Alberta, eingeladen worden war, die am 21. November 2025 stattfanden. Mit der jährl......
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
ADIL
LISTED
NASDAQ
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds
News Preview
GLEN ALLEN, Va., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced its entry into a warrant inducement agreement with an existing hea...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
GNLX
LISTED
NASDAQ
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference
News Preview
WESTLAKE VILLAGE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Co...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
SBTX
LISTED
NASDAQ
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
News Preview
SAN DIEGO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced its participation at the Piper Sandler 37th Annual Healthcare Conferen...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
DSGN
LISTED
NASDAQ
Design Therapeutics to Participate in Upcoming Investor Conferences
News Preview
CARLSBAD, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in fireside chats at the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
KRYS
LISTED
NASDAQ
Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference
News Preview
PITTSBURGH, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025, in Miami. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:00 am ET and...
Themefolio
Profiler
Peergroup
© Newsfile
26.11.2025
PREV
LISTED
CSE
PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement
News Preview
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") and BioGene Therapeutics Inc. ("BioGene"), are pleased to announce that, further...
Themefolio
Profiler
Peergroup
© Newsfile
26.11.2025
OPTI
LISTED
CSE
Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD
News Preview
Approved multicenter study sponsored by Sheba Medical Center to compare group and individual MDMA-assisted therapy for 168 patients experiencing trauma-related PTSDVancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian manufacturer of phar...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
NVCR
LISTED
NASDAQ
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
News Preview
Novocure (NASDAQ: NVCR) announced today that management will participate in the 37th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 2, 2025. William Doyle, Novocure’s Executive Chairman, will take part in a fireside chat at 11:30 a.m. ET, as well as one-on-one meetings with investors throughout the event.
A live audio...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
BMY
LISTED
NYSE
Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Citi’s 2025 Global Healthcare Conference on Thursday, December 4, 2025.
The company will take part in a fireside chat beginning at 9:00 a.m. ET.
Investors and the general public are invited to listen to the session by visiting http://investor.bms.com. An archiv...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
MRK
LISTED
NYSE
Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Chirfi Guindo, chief marketing officer, Human Health, and Dr. Eliav Barr, senior vice president, head of global clinical development and chief medical officer, Merck Research Laboratories, are scheduled to participate in a fireside chat at the 8th Annual...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2025
NUVL
LISTED
NASDAQ
Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference
News Preview
CAMBRIDGE, Mass., Nov. 26, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
BNTX
LISTED
NASDAQ
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
News Preview
MAINZ, Germany, November 26, 2025 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the approval of matters relating to the exchange offer (the “Offer”) for all outstanding shares of CureVac N.V. (Nasdaq: CVAC, “CureVac”) at the extraordinary general meeting (“EGM”) held by CureVac on November 25, 2025. At the EGM, over 99.16% of votes cast...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
